Pharming Group announces presentation of new leniolisib data at 2022 ASH Annual Meeting ...Middle East

Presentation to highlight data from the ongoing long-term open-label extension study of leniolisib, a PI3Kδ inhibitor under investigation for APDS, a rare primary immunodeficiency LEIDEN, Netherlands, Nov. 23, 2022 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company")...

Hence then, the article about pharming group announces presentation of new leniolisib data at 2022 ash annual meeting was published today ( Wednesday 23/11/2022 - 09:16 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Pharming Group announces presentation of new leniolisib data at 2022 ASH Annual Meeting )

Also on site :

• Karamo Brown Fell Out With 'Queer Eye' Co-Stars After Hot Mic Incident
• ‘Free Bert’ Review: Bert Kreischer Strips Away the Shirtless Party Boy Persona, but Also the Laughs, in New Netflix Comedy
• Lands' End and BaubleBar Just Dropped the Cutest Valentine's Day Tote and Charm Kit